

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.40484173 |
| 2 | synaptic vesicle maturation (GO:0016188) | 6.19109717 |
| 3 | locomotory exploration behavior (GO:0035641) | 5.96387070 |
| 4 | vocalization behavior (GO:0071625) | 5.77931376 |
| 5 | endocardial cushion development (GO:0003197) | 5.62474951 |
| 6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.62170260 |
| 7 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.58515844 |
| 8 | glutamate secretion (GO:0014047) | 5.51455637 |
| 9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.50266973 |
| 10 | neuron cell-cell adhesion (GO:0007158) | 5.47347850 |
| 11 | synaptic vesicle exocytosis (GO:0016079) | 5.25687786 |
| 12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.22703757 |
| 13 | exploration behavior (GO:0035640) | 5.20638515 |
| 14 | protein localization to synapse (GO:0035418) | 5.19754374 |
| 15 | layer formation in cerebral cortex (GO:0021819) | 5.19184849 |
| 16 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.15223692 |
| 17 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.81824753 |
| 18 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.75187267 |
| 19 | proline transport (GO:0015824) | 4.68724547 |
| 20 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.52055547 |
| 21 | regulation of synaptic vesicle transport (GO:1902803) | 4.50890961 |
| 22 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.49926474 |
| 23 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.46090496 |
| 24 | dendritic spine morphogenesis (GO:0060997) | 4.36461797 |
| 25 | neurotransmitter secretion (GO:0007269) | 4.32746444 |
| 26 | nodal signaling pathway (GO:0038092) | 4.31123307 |
| 27 | neuron recognition (GO:0008038) | 4.27786793 |
| 28 | * glutamate receptor signaling pathway (GO:0007215) | 4.15212344 |
| 29 | postsynaptic membrane organization (GO:0001941) | 4.09255961 |
| 30 | neuronal action potential propagation (GO:0019227) | 4.08058947 |
| 31 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.04879311 |
| 32 | positive regulation of synapse maturation (GO:0090129) | 4.04579221 |
| 33 | axonal fasciculation (GO:0007413) | 4.04136743 |
| 34 | synaptic transmission, glutamatergic (GO:0035249) | 4.03768153 |
| 35 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 3.97446642 |
| 36 | activation of protein kinase A activity (GO:0034199) | 3.97301230 |
| 37 | regulation of synapse structural plasticity (GO:0051823) | 3.94938710 |
| 38 | positive regulation of membrane potential (GO:0045838) | 3.92151027 |
| 39 | cell migration involved in heart development (GO:0060973) | 3.88304292 |
| 40 | long-term memory (GO:0007616) | 3.88168010 |
| 41 | gamma-aminobutyric acid transport (GO:0015812) | 3.87229238 |
| 42 | anterior/posterior axis specification, embryo (GO:0008595) | 3.85542309 |
| 43 | cellular potassium ion homeostasis (GO:0030007) | 3.80935112 |
| 44 | positive regulation of catecholamine secretion (GO:0033605) | 3.77867974 |
| 45 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.74778436 |
| 46 | collagen fibril organization (GO:0030199) | 3.74469198 |
| 47 | neuron-neuron synaptic transmission (GO:0007270) | 3.72332502 |
| 48 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.68068857 |
| 49 | positive regulation of fibroblast migration (GO:0010763) | 3.67678518 |
| 50 | chondrocyte proliferation (GO:0035988) | 3.66669291 |
| 51 | dendrite morphogenesis (GO:0048813) | 3.58790169 |
| 52 | regulation of synaptic plasticity (GO:0048167) | 3.58694484 |
| 53 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.58080858 |
| 54 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.57609124 |
| 55 | sodium ion export (GO:0071436) | 3.55991737 |
| 56 | neurotransmitter transport (GO:0006836) | 3.49193441 |
| 57 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 3.48691536 |
| 58 | regulation of postsynaptic membrane potential (GO:0060078) | 3.48276335 |
| 59 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.47960710 |
| 60 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.46906102 |
| 61 | presynaptic membrane assembly (GO:0097105) | 3.45332588 |
| 62 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.45254475 |
| 63 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.43961652 |
| 64 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.43959752 |
| 65 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.42230552 |
| 66 | skin morphogenesis (GO:0043589) | 3.35581529 |
| 67 | long-term synaptic potentiation (GO:0060291) | 3.34966150 |
| 68 | protein heterotrimerization (GO:0070208) | 3.34368455 |
| 69 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.34347535 |
| 70 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.32748144 |
| 71 | clathrin coat assembly (GO:0048268) | 3.32492920 |
| 72 | synaptic vesicle endocytosis (GO:0048488) | 3.30311596 |
| 73 | neuromuscular process controlling balance (GO:0050885) | 3.28652839 |
| 74 | regulation of neurotransmitter secretion (GO:0046928) | 3.27984194 |
| 75 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.27763104 |
| 76 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.27051331 |
| 77 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.27007070 |
| 78 | negative regulation of osteoblast proliferation (GO:0033689) | 3.25906767 |
| 79 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.25790332 |
| 80 | endothelial cell morphogenesis (GO:0001886) | 3.25728531 |
| 81 | regulation of dendritic spine development (GO:0060998) | 3.24692716 |
| 82 | cell communication by electrical coupling (GO:0010644) | 3.24622200 |
| 83 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.23231643 |
| 84 | regulation of vesicle fusion (GO:0031338) | 3.22943269 |
| 85 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.22805594 |
| 86 | transmission of nerve impulse (GO:0019226) | 3.22078509 |
| 87 | pericardium development (GO:0060039) | 3.21231982 |
| 88 | positive regulation of dendritic spine development (GO:0060999) | 3.20794501 |
| 89 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.20642389 |
| 90 | cell migration in hindbrain (GO:0021535) | 3.20364977 |
| 91 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.20197524 |
| 92 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.20088453 |
| 93 | vesicle transport along microtubule (GO:0047496) | 3.18720244 |
| 94 | regulation of neurotransmitter levels (GO:0001505) | 3.18322891 |
| 95 | presynaptic membrane organization (GO:0097090) | 3.13636949 |
| 96 | synapse assembly (GO:0007416) | 3.12486924 |
| 97 | sleep (GO:0030431) | 3.11427187 |
| 98 | behavioral defense response (GO:0002209) | 3.10685429 |
| 99 | behavioral fear response (GO:0001662) | 3.10685429 |
| 100 | neuromuscular process controlling posture (GO:0050884) | 3.09896430 |
| 101 | innervation (GO:0060384) | 3.08768746 |
| 102 | dendritic spine organization (GO:0097061) | 3.08426721 |
| 103 | cerebellar granule cell differentiation (GO:0021707) | 3.08244922 |
| 104 | organelle transport along microtubule (GO:0072384) | 3.05874601 |
| 105 | regulation of synapse maturation (GO:0090128) | 3.05475390 |
| 106 | lens morphogenesis in camera-type eye (GO:0002089) | 3.05059887 |
| 107 | suckling behavior (GO:0001967) | 3.04641068 |
| 108 | learning (GO:0007612) | 3.04147385 |
| 109 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.03138393 |
| 110 | negative regulation of amino acid transport (GO:0051956) | 3.02590241 |
| 111 | auditory behavior (GO:0031223) | 3.01005700 |
| 112 | social behavior (GO:0035176) | 3.00990541 |
| 113 | intraspecies interaction between organisms (GO:0051703) | 3.00990541 |
| 114 | cell adhesion mediated by integrin (GO:0033627) | 3.00483668 |
| 115 | endocrine hormone secretion (GO:0060986) | 3.00432842 |
| 116 | response to histamine (GO:0034776) | 2.99409200 |
| 117 | actin filament depolymerization (GO:0030042) | 2.96788997 |
| 118 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.96412442 |
| 119 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.95743387 |
| 120 | negative regulation of digestive system process (GO:0060457) | 2.95683685 |
| 121 | regulation of synaptic transmission (GO:0050804) | 2.95414284 |
| 122 | fear response (GO:0042596) | 2.95042208 |
| 123 | mating behavior (GO:0007617) | 2.94819630 |
| 124 | dermatan sulfate biosynthetic process (GO:0030208) | 2.94658374 |
| 125 | response to auditory stimulus (GO:0010996) | 2.93603882 |
| 126 | regulation of neurotransmitter transport (GO:0051588) | 2.93360473 |
| 127 | kidney mesenchyme development (GO:0072074) | 2.91748903 |
| 128 | positive regulation of synaptic transmission (GO:0050806) | 2.91718927 |
| 129 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.90973947 |
| 130 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.90232930 |
| 131 | nucleobase catabolic process (GO:0046113) | 2.89152664 |
| 132 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.89073645 |
| 133 | positive regulation of protein autophosphorylation (GO:0031954) | 2.87490529 |
| 134 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.86104141 |
| 135 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 2.84844723 |
| 136 | negative regulation of axon guidance (GO:1902668) | 2.82731921 |
| 137 | urinary tract smooth muscle contraction (GO:0014848) | 2.82102210 |
| 138 | inner ear receptor cell development (GO:0060119) | 2.80952056 |
| 139 | type B pancreatic cell proliferation (GO:0044342) | 2.79407173 |
| 140 | smooth muscle tissue development (GO:0048745) | 2.79182246 |
| 141 | dermatan sulfate metabolic process (GO:0030205) | 2.77443409 |
| 142 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.77338877 |
| 143 | regulation of extracellular matrix disassembly (GO:0010715) | 2.76689145 |
| 144 | substrate-dependent cell migration (GO:0006929) | 2.70702716 |
| 145 | response to gravity (GO:0009629) | 2.70686559 |
| 146 | virion attachment to host cell (GO:0019062) | 2.70541643 |
| 147 | adhesion of symbiont to host cell (GO:0044650) | 2.70541643 |
| 148 | negative regulation of bone remodeling (GO:0046851) | 2.66163654 |
| 149 | ventricular septum development (GO:0003281) | 2.66006251 |
| 150 | metanephric mesenchyme development (GO:0072075) | 2.65390095 |
| 151 | positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511) | 2.64511802 |
| 152 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 2.64275347 |
| 153 | extracellular regulation of signal transduction (GO:1900115) | 2.62234810 |
| 154 | extracellular negative regulation of signal transduction (GO:1900116) | 2.62234810 |
| 155 | maternal behavior (GO:0042711) | 2.60931813 |
| 156 | basement membrane organization (GO:0071711) | 2.59718302 |
| 157 | regulation of organ formation (GO:0003156) | 2.57902186 |
| 158 | endodermal cell differentiation (GO:0035987) | 2.55427040 |
| 159 | cellular response to vitamin (GO:0071295) | 2.55352390 |
| 160 | neural crest cell development (GO:0014032) | 2.53952491 |
| 161 | blood vessel endothelial cell migration (GO:0043534) | 2.52522494 |
| 162 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.50623131 |
| 163 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.49648796 |
| 164 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 2.48705735 |
| 165 | negative regulation of BMP signaling pathway (GO:0030514) | 2.48224830 |
| 166 | negative regulation of myoblast differentiation (GO:0045662) | 2.46893487 |
| 167 | regulation of penile erection (GO:0060405) | 2.46121168 |
| 168 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.44635346 |
| 169 | cellular response to vitamin D (GO:0071305) | 2.43515375 |
| 170 | embryonic forelimb morphogenesis (GO:0035115) | 2.43466757 |
| 171 | activin receptor signaling pathway (GO:0032924) | 2.43391949 |
| 172 | regulation of axon guidance (GO:1902667) | 2.43053557 |
| 173 | embryonic process involved in female pregnancy (GO:0060136) | 2.43017906 |
| 174 | parental behavior (GO:0060746) | 2.42764693 |
| 175 | atrial septum morphogenesis (GO:0060413) | 2.41439142 |
| 176 | atrioventricular valve morphogenesis (GO:0003181) | 2.39193585 |
| 177 | positive regulation of male gonad development (GO:2000020) | 2.38850886 |
| 178 | response to dietary excess (GO:0002021) | 2.38733039 |
| 179 | regulation of male gonad development (GO:2000018) | 2.38043145 |
| 180 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.37212920 |
| 181 | peripheral nervous system development (GO:0007422) | 2.36751604 |
| 182 | protein localization to endosome (GO:0036010) | 2.35785569 |
| 183 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.35394505 |
| 184 | response to magnesium ion (GO:0032026) | 2.32913562 |
| 185 | sprouting angiogenesis (GO:0002040) | 2.32179131 |
| 186 | lymphangiogenesis (GO:0001946) | 2.31595982 |
| 187 | extracellular matrix assembly (GO:0085029) | 2.31415818 |
| 188 | positive regulation of neurotransmitter transport (GO:0051590) | 2.30220232 |
| 189 | positive regulation of axon extension (GO:0045773) | 2.28807179 |
| 190 | hypotonic response (GO:0006971) | 2.27757060 |
| 191 | positive regulation of transforming growth factor beta production (GO:0071636) | 2.26015250 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.19133517 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.30385246 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.29008162 |
| 4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.18106706 |
| 5 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.14310662 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.07810037 |
| 7 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.94683152 |
| 8 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.82800337 |
| 9 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.76984494 |
| 10 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.76984494 |
| 11 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.69802966 |
| 12 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.69454222 |
| 13 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.67365011 |
| 14 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.61147627 |
| 15 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.60878962 |
| 16 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.58253341 |
| 17 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.55477854 |
| 18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.53085584 |
| 19 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.50757037 |
| 20 | BRD4_25478319_ChIP-Seq_HGPS_Human | 2.50174355 |
| 21 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.45079529 |
| 22 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.38536574 |
| 23 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.35448143 |
| 24 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.33259775 |
| 25 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.30683233 |
| 26 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.28881177 |
| 27 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.27562862 |
| 28 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.21697403 |
| 29 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.16488779 |
| 30 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.10063330 |
| 31 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.07389866 |
| 32 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.07049563 |
| 33 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.03924566 |
| 34 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.95059046 |
| 35 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.91431312 |
| 36 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.89912784 |
| 37 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.88714592 |
| 38 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.87021652 |
| 39 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.86157938 |
| 40 | CJUN_26792858_Chip-Seq_BT549_Human | 1.85807885 |
| 41 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.84810458 |
| 42 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.79450443 |
| 43 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.75721819 |
| 44 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.73262134 |
| 45 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.73262134 |
| 46 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.64196248 |
| 47 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.60649863 |
| 48 | * ZNF274_21170338_ChIP-Seq_K562_Hela | 1.53699200 |
| 49 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.52370464 |
| 50 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.50747083 |
| 51 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.48267206 |
| 52 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.46819120 |
| 53 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.44436636 |
| 54 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.35770636 |
| 55 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.33454704 |
| 56 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.31259630 |
| 57 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.30856048 |
| 58 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.29157420 |
| 59 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.27550242 |
| 60 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.27060793 |
| 61 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.26835853 |
| 62 | P300_19829295_ChIP-Seq_ESCs_Human | 1.26664149 |
| 63 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.25759094 |
| 64 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.24655458 |
| 65 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.23033616 |
| 66 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.22628606 |
| 67 | AR_25329375_ChIP-Seq_VCAP_Human | 1.21989935 |
| 68 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.20288690 |
| 69 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.20151008 |
| 70 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.18416679 |
| 71 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.17805368 |
| 72 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17328020 |
| 73 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.16437318 |
| 74 | AR_19668381_ChIP-Seq_PC3_Human | 1.15643161 |
| 75 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.14105464 |
| 76 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.13967453 |
| 77 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.11960796 |
| 78 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.11445631 |
| 79 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11162695 |
| 80 | KDM2B_26808549_Chip-Seq_K562_Human | 1.10806040 |
| 81 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.08786819 |
| 82 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.08776777 |
| 83 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.08208696 |
| 84 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.07882055 |
| 85 | STAT3_23295773_ChIP-Seq_U87_Human | 1.07328044 |
| 86 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07209626 |
| 87 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.06434258 |
| 88 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.06267974 |
| 89 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.06169311 |
| 90 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.06101007 |
| 91 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.05555855 |
| 92 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.05150273 |
| 93 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.04542560 |
| 94 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.03883212 |
| 95 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.03709878 |
| 96 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.03678436 |
| 97 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.03381441 |
| 98 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.03302332 |
| 99 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02922211 |
| 100 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.02050417 |
| 101 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.01890873 |
| 102 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.01792238 |
| 103 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.00257544 |
| 104 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.99449796 |
| 105 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.99016674 |
| 106 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.99016674 |
| 107 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.97824627 |
| 108 | FUS_26573619_Chip-Seq_HEK293_Human | 0.97471659 |
| 109 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97150125 |
| 110 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.96103880 |
| 111 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95882071 |
| 112 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 0.95814039 |
| 113 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.95541279 |
| 114 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.95529046 |
| 115 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.94828693 |
| 116 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.94398138 |
| 117 | TCF4_23295773_ChIP-Seq_U87_Human | 0.94242386 |
| 118 | KDM2B_26808549_Chip-Seq_REH_Human | 0.92997836 |
| 119 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92889670 |
| 120 | TP53_16413492_ChIP-PET_HCT116_Human | 0.92403624 |
| 121 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.91401368 |
| 122 | RXR_22108803_ChIP-Seq_LS180_Human | 0.91253531 |
| 123 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.91182016 |
| 124 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.90621368 |
| 125 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.89772650 |
| 126 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.89707494 |
| 127 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.89562530 |
| 128 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.89467419 |
| 129 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.89249712 |
| 130 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.89174869 |
| 131 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89117691 |
| 132 | JUN_21703547_ChIP-Seq_K562_Human | 0.89013480 |
| 133 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.88687090 |
| 134 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.87979337 |
| 135 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.86844853 |
| 136 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86844853 |
| 137 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.86024029 |
| 138 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.85495050 |
| 139 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.85245493 |
| 140 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.84880184 |
| 141 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.84531115 |
| 142 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83419051 |
| 143 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.83355204 |
| 144 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.82288758 |
| 145 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.82165811 |
| 146 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82137772 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.94705688 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 5.58096551 |
| 3 | MP0003880_abnormal_central_pattern | 4.90223868 |
| 4 | MP0005503_abnormal_tendon_morphology | 4.29454920 |
| 5 | * MP0003635_abnormal_synaptic_transmissio | 4.23468539 |
| 6 | MP0004270_analgesia | 4.01759853 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 3.48263037 |
| 8 | MP0009384_cardiac_valve_regurgitation | 3.43032892 |
| 9 | MP0002063_abnormal_learning/memory/cond | 3.38237744 |
| 10 | MP0009745_abnormal_behavioral_response | 3.32359398 |
| 11 | MP0001958_emphysema | 3.29434451 |
| 12 | MP0005257_abnormal_intraocular_pressure | 3.19964581 |
| 13 | MP0003279_aneurysm | 3.15521311 |
| 14 | MP0005423_abnormal_somatic_nervous | 3.03563562 |
| 15 | MP0002064_seizures | 3.01585232 |
| 16 | MP0004272_abnormal_basement_membrane | 3.01067601 |
| 17 | MP0001968_abnormal_touch/_nociception | 2.92132991 |
| 18 | MP0009046_muscle_twitch | 2.83613681 |
| 19 | MP0002572_abnormal_emotion/affect_behav | 2.82698630 |
| 20 | MP0001542_abnormal_bone_strength | 2.80024481 |
| 21 | MP0002734_abnormal_mechanical_nocicepti | 2.75305221 |
| 22 | MP0009780_abnormal_chondrocyte_physiolo | 2.51637640 |
| 23 | MP0003950_abnormal_plasma_membrane | 2.51523091 |
| 24 | MP0001486_abnormal_startle_reflex | 2.47767674 |
| 25 | MP0001440_abnormal_grooming_behavior | 2.41558581 |
| 26 | MP0003329_amyloid_beta_deposits | 2.35799010 |
| 27 | MP0002735_abnormal_chemical_nociception | 2.28146298 |
| 28 | * MP0002272_abnormal_nervous_system | 2.26249902 |
| 29 | MP0002736_abnormal_nociception_after | 2.21924519 |
| 30 | MP0002733_abnormal_thermal_nociception | 2.18509521 |
| 31 | MP0001501_abnormal_sleep_pattern | 2.16079217 |
| 32 | MP0000778_abnormal_nervous_system | 2.12856626 |
| 33 | MP0005275_abnormal_skin_tensile | 2.11529643 |
| 34 | MP0010368_abnormal_lymphatic_system | 2.05706738 |
| 35 | MP0001970_abnormal_pain_threshold | 1.96491755 |
| 36 | MP0006054_spinal_hemorrhage | 1.94764431 |
| 37 | MP0003122_maternal_imprinting | 1.93367967 |
| 38 | MP0003941_abnormal_skin_development | 1.89123817 |
| 39 | MP0002184_abnormal_innervation | 1.86666082 |
| 40 | MP0004858_abnormal_nervous_system | 1.84998422 |
| 41 | MP0004811_abnormal_neuron_physiology | 1.83017105 |
| 42 | MP0002067_abnormal_sensory_capabilities | 1.81504671 |
| 43 | MP0003879_abnormal_hair_cell | 1.81194341 |
| 44 | MP0006276_abnormal_autonomic_nervous | 1.80809552 |
| 45 | MP0002822_catalepsy | 1.78417923 |
| 46 | MP0003787_abnormal_imprinting | 1.76466229 |
| 47 | MP0002557_abnormal_social/conspecific_i | 1.75369426 |
| 48 | MP0005645_abnormal_hypothalamus_physiol | 1.74349554 |
| 49 | MP0004924_abnormal_behavior | 1.72846714 |
| 50 | MP0005386_behavior/neurological_phenoty | 1.72846714 |
| 51 | MP0002295_abnormal_pulmonary_circulatio | 1.71101824 |
| 52 | MP0003091_abnormal_cell_migration | 1.67285534 |
| 53 | MP0010352_gastrointestinal_tract_polyps | 1.66863410 |
| 54 | MP0008569_lethality_at_weaning | 1.62929710 |
| 55 | MP0000955_abnormal_spinal_cord | 1.58664672 |
| 56 | MP0001299_abnormal_eye_distance/ | 1.58067381 |
| 57 | MP0002909_abnormal_adrenal_gland | 1.55899375 |
| 58 | MP0005023_abnormal_wound_healing | 1.54428106 |
| 59 | MP0004885_abnormal_endolymph | 1.49685885 |
| 60 | MP0000003_abnormal_adipose_tissue | 1.47599542 |
| 61 | MP0000534_abnormal_ureter_morphology | 1.47114597 |
| 62 | * MP0002066_abnormal_motor_capabilities/c | 1.40378948 |
| 63 | MP0002896_abnormal_bone_mineralization | 1.39880967 |
| 64 | * MP0002882_abnormal_neuron_morphology | 1.39421419 |
| 65 | MP0005595_abnormal_vascular_smooth | 1.36358943 |
| 66 | MP0005508_abnormal_skeleton_morphology | 1.34934632 |
| 67 | MP0001984_abnormal_olfaction | 1.34238132 |
| 68 | MP0003942_abnormal_urinary_system | 1.33390589 |
| 69 | MP0000767_abnormal_smooth_muscle | 1.30856591 |
| 70 | MP0002108_abnormal_muscle_morphology | 1.23811102 |
| 71 | MP0009250_abnormal_appendicular_skeleto | 1.21531039 |
| 72 | MP0001502_abnormal_circadian_rhythm | 1.20295870 |
| 73 | MP0004142_abnormal_muscle_tone | 1.19860857 |
| 74 | MP0003633_abnormal_nervous_system | 1.18650557 |
| 75 | MP0000538_abnormal_urinary_bladder | 1.16373379 |
| 76 | MP0002152_abnormal_brain_morphology | 1.15621556 |
| 77 | MP0000604_amyloidosis | 1.15413399 |
| 78 | MP0001243_abnormal_dermal_layer | 1.14950679 |
| 79 | MP0003566_abnormal_cell_adhesion | 1.14002814 |
| 80 | MP0001905_abnormal_dopamine_level | 1.13813585 |
| 81 | MP0010234_abnormal_vibrissa_follicle | 1.12369572 |
| 82 | MP0005646_abnormal_pituitary_gland | 1.12029776 |
| 83 | MP0000751_myopathy | 1.09621667 |
| 84 | MP0001756_abnormal_urination | 1.08316021 |
| 85 | MP0002060_abnormal_skin_morphology | 1.07840140 |
| 86 | MP0001529_abnormal_vocalization | 1.07127219 |
| 87 | MP0000639_abnormal_adrenal_gland | 1.04486143 |
| 88 | MP0003631_nervous_system_phenotype | 1.02152883 |
| 89 | MP0002069_abnormal_eating/drinking_beha | 0.97327781 |
| 90 | MP0002837_dystrophic_cardiac_calcinosis | 0.97203241 |
| 91 | MP0003045_fibrosis | 0.97015819 |
| 92 | MP0005187_abnormal_penis_morphology | 0.91202261 |
| 93 | MP0004134_abnormal_chest_morphology | 0.89943303 |
| 94 | MP0000427_abnormal_hair_cycle | 0.89869887 |
| 95 | MP0003868_abnormal_feces_composition | 0.89516883 |
| 96 | MP0001188_hyperpigmentation | 0.88050337 |
| 97 | MP0003283_abnormal_digestive_organ | 0.87556560 |
| 98 | MP0003123_paternal_imprinting | 0.87520218 |
| 99 | MP0008872_abnormal_physiological_respon | 0.87076352 |
| 100 | MP0005360_urolithiasis | 0.86604843 |
| 101 | MP0004145_abnormal_muscle_electrophysio | 0.86088853 |
| 102 | MP0000631_abnormal_neuroendocrine_gland | 0.85503154 |
| 103 | MP0001177_atelectasis | 0.84558256 |
| 104 | MP0004133_heterotaxia | 0.83284920 |
| 105 | MP0000013_abnormal_adipose_tissue | 0.82595855 |
| 106 | MP0004233_abnormal_muscle_weight | 0.82317028 |
| 107 | MP0000230_abnormal_systemic_arterial | 0.81449874 |
| 108 | MP0002115_abnormal_skeleton_extremities | 0.81327712 |
| 109 | MP0010386_abnormal_urinary_bladder | 0.81027815 |
| 110 | MP0002102_abnormal_ear_morphology | 0.80704003 |
| 111 | MP0008961_abnormal_basal_metabolism | 0.79834486 |
| 112 | MP0002229_neurodegeneration | 0.79750931 |
| 113 | MP0005535_abnormal_body_temperature | 0.79055723 |
| 114 | MP0004742_abnormal_vestibular_system | 0.78570303 |
| 115 | MP0003634_abnormal_glial_cell | 0.78345263 |
| 116 | MP0001963_abnormal_hearing_physiology | 0.78334600 |
| 117 | MP0003075_altered_response_to | 0.77058427 |
| 118 | MP0009053_abnormal_anal_canal | 0.75807809 |
| 119 | MP0001664_abnormal_digestion | 0.75682054 |
| 120 | MP0003632_abnormal_nervous_system | 0.74414867 |
| 121 | MP0000462_abnormal_digestive_system | 0.74144860 |
| 122 | MP0001944_abnormal_pancreas_morphology | 0.72735461 |
| 123 | MP0008775_abnormal_heart_ventricle | 0.72155740 |
| 124 | MP0001348_abnormal_lacrimal_gland | 0.71528712 |
| 125 | MP0008874_decreased_physiological_sensi | 0.71215896 |
| 126 | MP0004085_abnormal_heartbeat | 0.70339264 |
| 127 | MP0003690_abnormal_glial_cell | 0.69387996 |
| 128 | MP0003252_abnormal_bile_duct | 0.69089784 |
| 129 | MP0000569_abnormal_digit_pigmentation | 0.66725522 |
| 130 | * MP0002752_abnormal_somatic_nervous | 0.66090416 |
| 131 | MP0005197_abnormal_uvea_morphology | 0.65903789 |
| 132 | MP0005620_abnormal_muscle_contractility | 0.65398910 |
| 133 | MP0003172_abnormal_lysosome_physiology | 0.64603499 |
| 134 | MP0005164_abnormal_response_to | 0.64568656 |
| 135 | MP0003861_abnormal_nervous_system | 0.64529430 |
| 136 | MP0001879_abnormal_lymphatic_vessel | 0.63693585 |
| 137 | MP0003121_genomic_imprinting | 0.63545130 |
| 138 | MP0000920_abnormal_myelination | 0.63392863 |
| 139 | MP0005409_darkened_coat_color | 0.63196108 |
| 140 | MP0005394_taste/olfaction_phenotype | 0.62968126 |
| 141 | MP0005499_abnormal_olfactory_system | 0.62968126 |
| 142 | MP0002168_other_aberrant_phenotype | 0.62857984 |
| 143 | MP0004036_abnormal_muscle_relaxation | 0.62800217 |
| 144 | MP0009840_abnormal_foam_cell | 0.62359156 |
| 145 | MP0005167_abnormal_blood-brain_barrier | 0.61546655 |
| 146 | MP0000733_abnormal_muscle_development | 0.60296061 |
| 147 | MP0004484_altered_response_of | 0.59961559 |
| 148 | * MP0005551_abnormal_eye_electrophysiolog | 0.59081577 |
| 149 | MP0003959_abnormal_lean_body | 0.58353200 |
| 150 | MP0003937_abnormal_limbs/digits/tail_de | 0.57911329 |
| 151 | MP0005623_abnormal_meninges_morphology | 0.56893823 |
| 152 | MP0004215_abnormal_myocardial_fiber | 0.56217875 |
| 153 | MP0000163_abnormal_cartilage_morphology | 0.55953226 |
| 154 | MP0003137_abnormal_impulse_conducting | 0.55523364 |
| 155 | MP0005390_skeleton_phenotype | 0.55415637 |
| 156 | MP0005367_renal/urinary_system_phenotyp | 0.54818589 |
| 157 | MP0000516_abnormal_urinary_system | 0.54818589 |
| 158 | MP0002090_abnormal_vision | 0.54738797 |
| 159 | MP0002876_abnormal_thyroid_physiology | 0.53799276 |
| 160 | MP0010769_abnormal_survival | 0.52427360 |
| 161 | MP0001485_abnormal_pinna_reflex | 0.51960770 |
| 162 | MP0001943_abnormal_respiration | 0.51788924 |
| 163 | MP0000026_abnormal_inner_ear | 0.51501383 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.69753963 |
| 2 | Premature rupture of membranes (HP:0001788) | 6.51584605 |
| 3 | Myokymia (HP:0002411) | 6.35015154 |
| 4 | Protrusio acetabuli (HP:0003179) | 5.80924683 |
| 5 | Visual hallucinations (HP:0002367) | 5.57830437 |
| 6 | Focal seizures (HP:0007359) | 5.51398530 |
| 7 | Epileptic encephalopathy (HP:0200134) | 4.73148948 |
| 8 | Aortic aneurysm (HP:0004942) | 4.57270979 |
| 9 | Mutism (HP:0002300) | 4.20137041 |
| 10 | Supranuclear gaze palsy (HP:0000605) | 4.00002546 |
| 11 | Atonic seizures (HP:0010819) | 3.99624851 |
| 12 | Aortic dissection (HP:0002647) | 3.97797579 |
| 13 | Ankle contracture (HP:0006466) | 3.96943688 |
| 14 | Absence seizures (HP:0002121) | 3.91209194 |
| 15 | Follicular hyperkeratosis (HP:0007502) | 3.90504644 |
| 16 | Progressive cerebellar ataxia (HP:0002073) | 3.85226186 |
| 17 | Sparse lateral eyebrow (HP:0005338) | 3.81102055 |
| 18 | Generalized tonic-clonic seizures (HP:0002069) | 3.79595564 |
| 19 | Papilledema (HP:0001085) | 3.74162762 |
| 20 | Broad-based gait (HP:0002136) | 3.62366953 |
| 21 | Type 1 muscle fiber predominance (HP:0003803) | 3.58894738 |
| 22 | Aplasia of the musculature (HP:0100854) | 3.57671116 |
| 23 | Dialeptic seizures (HP:0011146) | 3.54326352 |
| 24 | Cerebral inclusion bodies (HP:0100314) | 3.52248651 |
| 25 | Neurofibrillary tangles (HP:0002185) | 3.51360687 |
| 26 | Febrile seizures (HP:0002373) | 3.44290245 |
| 27 | Vascular tortuosity (HP:0004948) | 3.43314011 |
| 28 | Hyperventilation (HP:0002883) | 3.43231023 |
| 29 | Ankle clonus (HP:0011448) | 3.40187869 |
| 30 | Poor eye contact (HP:0000817) | 3.37337305 |
| 31 | Cardiovascular calcification (HP:0011915) | 3.35463717 |
| 32 | Genu recurvatum (HP:0002816) | 3.31754114 |
| 33 | Action tremor (HP:0002345) | 3.29640628 |
| 34 | Broad metatarsal (HP:0001783) | 3.29539341 |
| 35 | Spinal rigidity (HP:0003306) | 3.27347244 |
| 36 | Abnormal eating behavior (HP:0100738) | 3.21994622 |
| 37 | Abnormality of dentin (HP:0010299) | 3.20093529 |
| 38 | Slender build (HP:0001533) | 3.19608181 |
| 39 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.19002001 |
| 40 | Excessive salivation (HP:0003781) | 3.17254760 |
| 41 | Drooling (HP:0002307) | 3.17254760 |
| 42 | Depression (HP:0000716) | 3.13100754 |
| 43 | Atrophic scars (HP:0001075) | 3.12075022 |
| 44 | Amyotrophic lateral sclerosis (HP:0007354) | 3.11920605 |
| 45 | Polyphagia (HP:0002591) | 3.10841010 |
| 46 | Abnormality of the corticospinal tract (HP:0002492) | 3.10685299 |
| 47 | Soft skin (HP:0000977) | 3.09527258 |
| 48 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.05041021 |
| 49 | Impaired social interactions (HP:0000735) | 3.00481225 |
| 50 | Abnormal social behavior (HP:0012433) | 3.00481225 |
| 51 | Wormian bones (HP:0002645) | 2.99757552 |
| 52 | Neonatal short-limb short stature (HP:0008921) | 2.96512943 |
| 53 | Termporal pattern (HP:0011008) | 2.93886241 |
| 54 | Insidious onset (HP:0003587) | 2.93886241 |
| 55 | Bladder diverticulum (HP:0000015) | 2.93279261 |
| 56 | Cervical subluxation (HP:0003308) | 2.89701189 |
| 57 | Anxiety (HP:0000739) | 2.87002689 |
| 58 | Shallow orbits (HP:0000586) | 2.86157500 |
| 59 | Dysmetria (HP:0001310) | 2.82780837 |
| 60 | Limb dystonia (HP:0002451) | 2.82688949 |
| 61 | Abnormality of the lower motor neuron (HP:0002366) | 2.81785323 |
| 62 | Gaze-evoked nystagmus (HP:0000640) | 2.81761744 |
| 63 | Mitral stenosis (HP:0001718) | 2.81029738 |
| 64 | Urinary urgency (HP:0000012) | 2.77297529 |
| 65 | Dysdiadochokinesis (HP:0002075) | 2.77254735 |
| 66 | Amblyopia (HP:0000646) | 2.77027424 |
| 67 | Fragile skin (HP:0001030) | 2.76127243 |
| 68 | Arterial tortuosity (HP:0005116) | 2.73369128 |
| 69 | Vascular calcification (HP:0004934) | 2.71034762 |
| 70 | Torticollis (HP:0000473) | 2.69455662 |
| 71 | Bowel diverticulosis (HP:0005222) | 2.69433697 |
| 72 | Truncal ataxia (HP:0002078) | 2.67485507 |
| 73 | Postural instability (HP:0002172) | 2.67468572 |
| 74 | Abnormality of binocular vision (HP:0011514) | 2.66227068 |
| 75 | Diplopia (HP:0000651) | 2.66227068 |
| 76 | Akinesia (HP:0002304) | 2.66110774 |
| 77 | Peritonitis (HP:0002586) | 2.62044464 |
| 78 | Genetic anticipation (HP:0003743) | 2.57643336 |
| 79 | Overgrowth (HP:0001548) | 2.53993516 |
| 80 | Agitation (HP:0000713) | 2.52172725 |
| 81 | Stereotypic behavior (HP:0000733) | 2.51991682 |
| 82 | Epileptiform EEG discharges (HP:0011182) | 2.51964807 |
| 83 | Ulnar bowing (HP:0003031) | 2.51791910 |
| 84 | Hemiparesis (HP:0001269) | 2.51074568 |
| 85 | Spastic gait (HP:0002064) | 2.50880675 |
| 86 | Inappropriate behavior (HP:0000719) | 2.50212299 |
| 87 | Focal dystonia (HP:0004373) | 2.49492369 |
| 88 | EEG with generalized epileptiform discharges (HP:0011198) | 2.46473684 |
| 89 | Wide anterior fontanel (HP:0000260) | 2.46014440 |
| 90 | Progressive inability to walk (HP:0002505) | 2.45485929 |
| 91 | Bradykinesia (HP:0002067) | 2.41705253 |
| 92 | Abnormality of proline metabolism (HP:0010907) | 2.41651376 |
| 93 | Hydroxyprolinuria (HP:0003080) | 2.41651376 |
| 94 | Coronal craniosynostosis (HP:0004440) | 2.40995428 |
| 95 | Spondylolisthesis (HP:0003302) | 2.40929704 |
| 96 | Absent speech (HP:0001344) | 2.39783024 |
| 97 | Obstructive sleep apnea (HP:0002870) | 2.38972487 |
| 98 | Hypsarrhythmia (HP:0002521) | 2.34983852 |
| 99 | Apathy (HP:0000741) | 2.33428085 |
| 100 | Fetal akinesia sequence (HP:0001989) | 2.32768131 |
| 101 | Megalencephaly (HP:0001355) | 2.32467719 |
| 102 | Intention tremor (HP:0002080) | 2.31933058 |
| 103 | Dilatation of the ascending aorta (HP:0005111) | 2.31387398 |
| 104 | Aortic regurgitation (HP:0001659) | 2.29889903 |
| 105 | Increased variability in muscle fiber diameter (HP:0003557) | 2.29821593 |
| 106 | Inability to walk (HP:0002540) | 2.29254174 |
| 107 | Mitral regurgitation (HP:0001653) | 2.28729562 |
| 108 | Impaired smooth pursuit (HP:0007772) | 2.27604482 |
| 109 | Craniofacial dystonia (HP:0012179) | 2.27419637 |
| 110 | Generalized myoclonic seizures (HP:0002123) | 2.27401047 |
| 111 | Elbow flexion contracture (HP:0002987) | 2.26906497 |
| 112 | Blue sclerae (HP:0000592) | 2.26260144 |
| 113 | Lower limb muscle weakness (HP:0007340) | 2.25806845 |
| 114 | Abnormality of carpal bone ossification (HP:0006257) | 2.25429304 |
| 115 | Abnormal delivery (HP:0001787) | 2.21977927 |
| 116 | Bradycardia (HP:0001662) | 2.20947218 |
| 117 | Pheochromocytoma (HP:0002666) | 2.20386070 |
| 118 | Sleep apnea (HP:0010535) | 2.18090282 |
| 119 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.17783739 |
| 120 | Status epilepticus (HP:0002133) | 2.15525285 |
| 121 | Menstrual irregularities (HP:0000858) | 2.15438129 |
| 122 | Lower limb amyotrophy (HP:0007210) | 2.14671599 |
| 123 | Aneurysm (HP:0002617) | 2.11740673 |
| 124 | Mild short stature (HP:0003502) | 2.10892784 |
| 125 | Hyperextensible skin (HP:0000974) | 2.10717571 |
| 126 | Insomnia (HP:0100785) | 2.09466004 |
| 127 | Scanning speech (HP:0002168) | 2.08589347 |
| 128 | Neuronal loss in central nervous system (HP:0002529) | 2.08536870 |
| 129 | Abnormality of salivation (HP:0100755) | 2.08368418 |
| 130 | Diminished motivation (HP:0000745) | 2.08365727 |
| 131 | Joint laxity (HP:0001388) | 2.07747884 |
| 132 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.07211277 |
| 133 | Vertebral compression fractures (HP:0002953) | 2.05908790 |
| 134 | Hemiplegia (HP:0002301) | 2.05034477 |
| 135 | Ventricular fibrillation (HP:0001663) | 2.04643268 |
| 136 | Upper limb amyotrophy (HP:0009129) | 2.04597884 |
| 137 | Distal upper limb amyotrophy (HP:0007149) | 2.04597884 |
| 138 | Short clavicles (HP:0000894) | 2.03403386 |
| 139 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.99639180 |
| 140 | Hypoventilation (HP:0002791) | 1.99542005 |
| 141 | Impaired vibratory sensation (HP:0002495) | 1.98886682 |
| 142 | Osteolytic defects of the hand bones (HP:0009699) | 1.96797272 |
| 143 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.96797272 |
| 144 | Mitral valve prolapse (HP:0001634) | 1.95466042 |
| 145 | Neuroendocrine neoplasm (HP:0100634) | 1.95283373 |
| 146 | Round ear (HP:0100830) | 1.95179198 |
| 147 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.94635646 |
| 148 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.94635646 |
| 149 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.94436244 |
| 150 | Failure to thrive in infancy (HP:0001531) | 1.94065375 |
| 151 | Psychosis (HP:0000709) | 1.93414532 |
| 152 | Increased number of teeth (HP:0011069) | 1.93119357 |
| 153 | Rapidly progressive (HP:0003678) | 1.93094543 |
| 154 | Aortic valve stenosis (HP:0001650) | 1.92204412 |
| 155 | Long toe (HP:0010511) | 1.92097971 |
| 156 | Clonus (HP:0002169) | 1.91865938 |
| 157 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.91626080 |
| 158 | Mucopolysacchariduria (HP:0008155) | 1.91626080 |
| 159 | Hyperthyroidism (HP:0000836) | 1.89491199 |
| 160 | Pointed chin (HP:0000307) | 1.87752607 |
| 161 | Ankyloglossia (HP:0010296) | 1.87476813 |
| 162 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.86863631 |
| 163 | Biconcave vertebral bodies (HP:0004586) | 1.86414097 |
| 164 | Abnormal ossification of hand bones (HP:0005921) | 1.86198917 |
| 165 | Short 1st metacarpal (HP:0010034) | 1.85013202 |
| 166 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.85013202 |
| 167 | Deviation of the hallux (HP:0010051) | 1.83607979 |
| 168 | Hyperphosphatemia (HP:0002905) | 1.83178638 |
| 169 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.82679361 |
| 170 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.82679361 |
| 171 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.82679361 |
| 172 | Osteoarthritis (HP:0002758) | 1.82159446 |
| 173 | Syringomyelia (HP:0003396) | 1.82049147 |
| 174 | Spinal cord lesions (HP:0100561) | 1.82049147 |
| 175 | Abnormality of the acetabulum (HP:0003170) | 1.81601503 |
| 176 | Gait ataxia (HP:0002066) | 1.81119868 |
| 177 | Blue irides (HP:0000635) | 1.80012850 |
| 178 | Abnormality of the Achilles tendon (HP:0005109) | 1.76704933 |
| 179 | Morphological abnormality of the middle ear (HP:0008609) | 1.75992457 |
| 180 | Wrist flexion contracture (HP:0001239) | 1.74782766 |
| 181 | Hand muscle atrophy (HP:0009130) | 1.74414968 |
| 182 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.73117577 |
| 183 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.70166931 |
| 184 | Achilles tendon contracture (HP:0001771) | 1.69952305 |
| 185 | Mesomelia (HP:0003027) | 1.69067637 |
| 186 | Atrioventricular canal defect (HP:0006695) | 1.68907392 |
| 187 | Camptodactyly of toe (HP:0001836) | 1.68462978 |
| 188 | Short nail (HP:0001799) | 1.68359192 |
| 189 | Breast hypoplasia (HP:0003187) | 1.67880863 |
| 190 | Limb-girdle muscle weakness (HP:0003325) | 1.67289445 |
| 191 | Partial duplication of the phalanx of hand (HP:0009999) | 1.65869037 |
| 192 | Aplasia/Hypoplasia of the clavicles (HP:0006710) | 1.64870910 |
| 193 | Redundant skin (HP:0001582) | 1.64766011 |
| 194 | Abnormal hand bone ossification (HP:0010660) | 1.64687907 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | AKT3 | 8.66734365 |
| 2 | MAP3K9 | 4.85252113 |
| 3 | MARK1 | 4.69774476 |
| 4 | MYLK | 4.44271612 |
| 5 | NTRK3 | 4.37691902 |
| 6 | EPHA4 | 3.82069623 |
| 7 | MAP3K4 | 2.74168521 |
| 8 | MINK1 | 2.70734586 |
| 9 | KSR2 | 2.48342884 |
| 10 | PTK2 | 2.44959298 |
| 11 | PRKD2 | 2.41760374 |
| 12 | DAPK2 | 2.34968501 |
| 13 | PAK6 | 2.23524948 |
| 14 | PDGFRA | 2.20463687 |
| 15 | MAP2K7 | 2.17609203 |
| 16 | NTRK2 | 2.13015240 |
| 17 | PAK2 | 2.11052962 |
| 18 | FRK | 2.10262902 |
| 19 | NEK9 | 2.04997243 |
| 20 | MAP3K12 | 2.01937346 |
| 21 | KSR1 | 2.00870856 |
| 22 | LIMK1 | 1.93692023 |
| 23 | TRPM7 | 1.91750174 |
| 24 | NTRK1 | 1.90862249 |
| 25 | MAP2K4 | 1.74819223 |
| 26 | ARAF | 1.63080589 |
| 27 | SIK2 | 1.62434362 |
| 28 | PLK2 | 1.61260614 |
| 29 | RIPK1 | 1.59769896 |
| 30 | LATS2 | 1.59051475 |
| 31 | CDK5 | 1.53748316 |
| 32 | ERBB4 | 1.50431389 |
| 33 | CAMKK1 | 1.48234965 |
| 34 | TTN | 1.46320805 |
| 35 | MAPK13 | 1.44591956 |
| 36 | RIPK4 | 1.41374572 |
| 37 | CASK | 1.41300160 |
| 38 | PRKD3 | 1.40827617 |
| 39 | MAP3K2 | 1.38719870 |
| 40 | DAPK1 | 1.38373005 |
| 41 | TESK1 | 1.37489930 |
| 42 | PHKG2 | 1.36893676 |
| 43 | PHKG1 | 1.36893676 |
| 44 | TNIK | 1.28441411 |
| 45 | PNCK | 1.26699836 |
| 46 | MAP3K13 | 1.25413018 |
| 47 | PRKG2 | 1.22189177 |
| 48 | GRK5 | 1.20745918 |
| 49 | PRPF4B | 1.20542627 |
| 50 | CDK19 | 1.15809646 |
| 51 | PRKCG | 1.15752504 |
| 52 | SIK1 | 1.11629210 |
| 53 | PAK3 | 1.09561680 |
| 54 | UHMK1 | 1.07932416 |
| 55 | CSNK1G2 | 1.03320083 |
| 56 | ROCK1 | 1.01011216 |
| 57 | RAF1 | 1.00922929 |
| 58 | TAOK1 | 1.00748020 |
| 59 | ADRBK1 | 0.97170177 |
| 60 | ABL2 | 0.96963317 |
| 61 | STK38 | 0.95416176 |
| 62 | RET | 0.94163890 |
| 63 | CDK18 | 0.92666893 |
| 64 | CDK15 | 0.92155131 |
| 65 | PIK3CG | 0.91803063 |
| 66 | FES | 0.91652979 |
| 67 | CDK14 | 0.91345174 |
| 68 | CAMK2A | 0.90816077 |
| 69 | TYRO3 | 0.90775822 |
| 70 | LATS1 | 0.88181085 |
| 71 | PDGFRB | 0.87207980 |
| 72 | STK11 | 0.82048784 |
| 73 | MELK | 0.79744050 |
| 74 | CDK11A | 0.79430962 |
| 75 | CAMK1 | 0.78303315 |
| 76 | ROCK2 | 0.76232015 |
| 77 | MET | 0.75869719 |
| 78 | DYRK1A | 0.70570386 |
| 79 | MARK2 | 0.70245692 |
| 80 | MAP3K1 | 0.69626779 |
| 81 | CCNB1 | 0.69493612 |
| 82 | GRK7 | 0.68230619 |
| 83 | BRSK2 | 0.68140555 |
| 84 | PRKCH | 0.67950415 |
| 85 | SCYL2 | 0.67659628 |
| 86 | CAMK2D | 0.67142413 |
| 87 | PDPK1 | 0.65181308 |
| 88 | ERBB3 | 0.64971178 |
| 89 | ALK | 0.64063385 |
| 90 | CAMK2B | 0.63795426 |
| 91 | MTOR | 0.63718647 |
| 92 | CDC42BPA | 0.62160013 |
| 93 | PDK1 | 0.61895477 |
| 94 | GSK3A | 0.60240070 |
| 95 | HIPK2 | 0.59432980 |
| 96 | BRSK1 | 0.59392925 |
| 97 | SGK1 | 0.59329804 |
| 98 | MAPKAPK3 | 0.59031366 |
| 99 | LMTK2 | 0.58283005 |
| 100 | MAPK11 | 0.57498826 |
| 101 | SGK494 | 0.56628067 |
| 102 | SGK223 | 0.56628067 |
| 103 | PTK2B | 0.56069558 |
| 104 | EEF2K | 0.55735067 |
| 105 | PRKCZ | 0.55699237 |
| 106 | OXSR1 | 0.55012927 |
| 107 | MAP2K6 | 0.54399698 |
| 108 | ERN1 | 0.53555329 |
| 109 | DYRK2 | 0.52274934 |
| 110 | CAMK1G | 0.51541649 |
| 111 | PRKD1 | 0.49360670 |
| 112 | PAK4 | 0.47282551 |
| 113 | MAP2K1 | 0.47195007 |
| 114 | CSNK1G3 | 0.46501573 |
| 115 | PKN1 | 0.46193786 |
| 116 | FYN | 0.45924600 |
| 117 | MAP3K6 | 0.45768973 |
| 118 | FER | 0.45413375 |
| 119 | CDK12 | 0.44303380 |
| 120 | MAPK12 | 0.43455670 |
| 121 | PRKCE | 0.43326803 |
| 122 | JAK1 | 0.43196007 |
| 123 | PRKAA1 | 0.43059430 |
| 124 | ACVR1B | 0.43007890 |
| 125 | TRIB3 | 0.42174573 |
| 126 | RPS6KA3 | 0.41650263 |
| 127 | FGFR3 | 0.41066732 |
| 128 | DMPK | 0.40946538 |
| 129 | BRAF | 0.40912993 |
| 130 | CAMK2G | 0.40871582 |
| 131 | CAMKK2 | 0.40594659 |
| 132 | MAPK7 | 0.40463318 |
| 133 | BMPR2 | 0.39442842 |
| 134 | CSNK1A1L | 0.39064394 |
| 135 | DYRK1B | 0.38768627 |
| 136 | TAOK2 | 0.38603077 |
| 137 | MOS | 0.38378238 |
| 138 | SGK2 | 0.38348791 |
| 139 | GRK1 | 0.37582579 |
| 140 | SGK3 | 0.36499182 |
| 141 | NME1 | 0.36364866 |
| 142 | FGR | 0.35572433 |
| 143 | MAPK10 | 0.34694821 |
| 144 | WNK1 | 0.34376966 |
| 145 | RPS6KA2 | 0.34331855 |
| 146 | FGFR2 | 0.33811567 |
| 147 | PAK1 | 0.32357863 |
| 148 | DAPK3 | 0.32244016 |
| 149 | DDR2 | 0.30960758 |
| 150 | NEK6 | 0.29956059 |
| 151 | WNK3 | 0.29061043 |
| 152 | EPHB1 | 0.28918676 |
| 153 | SRC | 0.28824197 |
| 154 | EPHB2 | 0.28499852 |
| 155 | PRKG1 | 0.27584025 |
| 156 | ICK | 0.27537831 |
| 157 | WNK4 | 0.26313579 |
| 158 | PINK1 | 0.26024556 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.53914200 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.21575655 |
| 3 | Circadian entrainment_Homo sapiens_hsa04713 | 2.68781840 |
| 4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.61149042 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.60715743 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.60120677 |
| 7 | Olfactory transduction_Homo sapiens_hsa04740 | 2.51091324 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.50226387 |
| 9 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.42811154 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.35334208 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.33378706 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.17775448 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.13283092 |
| 14 | Gastric acid secretion_Homo sapiens_hsa04971 | 2.00056927 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.96793367 |
| 16 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.94844000 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.87865175 |
| 18 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.82642273 |
| 19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.82405015 |
| 20 | Focal adhesion_Homo sapiens_hsa04510 | 1.82220329 |
| 21 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.77793589 |
| 22 | Renin secretion_Homo sapiens_hsa04924 | 1.74161839 |
| 23 | Long-term depression_Homo sapiens_hsa04730 | 1.72352634 |
| 24 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.69702836 |
| 25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.65418684 |
| 26 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.65392340 |
| 27 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.63151232 |
| 28 | Taste transduction_Homo sapiens_hsa04742 | 1.60954403 |
| 29 | Cocaine addiction_Homo sapiens_hsa05030 | 1.60294872 |
| 30 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.54278285 |
| 31 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.49687990 |
| 32 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.48833607 |
| 33 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.47632170 |
| 34 | Gap junction_Homo sapiens_hsa04540 | 1.44676283 |
| 35 | Axon guidance_Homo sapiens_hsa04360 | 1.41963373 |
| 36 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.38360337 |
| 37 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.32777954 |
| 38 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.30864934 |
| 39 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.29437291 |
| 40 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.27453507 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.27156287 |
| 42 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.27003351 |
| 43 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 1.19570325 |
| 44 | Glioma_Homo sapiens_hsa05214 | 1.19497075 |
| 45 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.19031620 |
| 46 | Melanogenesis_Homo sapiens_hsa04916 | 1.16195118 |
| 47 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.16061437 |
| 48 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.15284647 |
| 49 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.12660390 |
| 50 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.10018308 |
| 51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.09748208 |
| 52 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.09270246 |
| 53 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.02733086 |
| 54 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.01657467 |
| 55 | Melanoma_Homo sapiens_hsa05218 | 1.00027585 |
| 56 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.99809686 |
| 57 | Other glycan degradation_Homo sapiens_hsa00511 | 0.97045074 |
| 58 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.96683706 |
| 59 | Circadian rhythm_Homo sapiens_hsa04710 | 0.94118732 |
| 60 | Amoebiasis_Homo sapiens_hsa05146 | 0.93556985 |
| 61 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.93418095 |
| 62 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.93127468 |
| 63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.92286757 |
| 64 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.91779913 |
| 65 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.90015076 |
| 66 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.86964366 |
| 67 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.86231241 |
| 68 | Adherens junction_Homo sapiens_hsa04520 | 0.82047719 |
| 69 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.81799504 |
| 70 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.81362997 |
| 71 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.79867279 |
| 72 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.79009287 |
| 73 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.78564714 |
| 74 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.76364803 |
| 75 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.75006239 |
| 76 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.73688580 |
| 77 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.73569160 |
| 78 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.73391259 |
| 79 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.71669477 |
| 80 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71542873 |
| 81 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.71542370 |
| 82 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.71286568 |
| 83 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.70723156 |
| 84 | Prion diseases_Homo sapiens_hsa05020 | 0.70710916 |
| 85 | Endometrial cancer_Homo sapiens_hsa05213 | 0.70285940 |
| 86 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.69420396 |
| 87 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.69274539 |
| 88 | Tight junction_Homo sapiens_hsa04530 | 0.68345627 |
| 89 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.67472314 |
| 90 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.66599214 |
| 91 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65764118 |
| 92 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.65761871 |
| 93 | Bile secretion_Homo sapiens_hsa04976 | 0.64795627 |
| 94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64520034 |
| 95 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.63046142 |
| 96 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.60134832 |
| 97 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58049441 |
| 98 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.55820258 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55489699 |
| 100 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.54756289 |
| 101 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53855854 |
| 102 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.53125431 |
| 103 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.52006295 |
| 104 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.49853358 |
| 105 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.49813114 |
| 106 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.49463754 |
| 107 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.49435230 |
| 108 | Phototransduction_Homo sapiens_hsa04744 | 0.49330624 |
| 109 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.48495432 |
| 110 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.48431323 |
| 111 | Alcoholism_Homo sapiens_hsa05034 | 0.48223020 |
| 112 | Colorectal cancer_Homo sapiens_hsa05210 | 0.47685491 |
| 113 | Mineral absorption_Homo sapiens_hsa04978 | 0.46895388 |
| 114 | Endocytosis_Homo sapiens_hsa04144 | 0.45917560 |
| 115 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.45523971 |
| 116 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.45476452 |
| 117 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.45379518 |
| 118 | Platelet activation_Homo sapiens_hsa04611 | 0.45085276 |
| 119 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.45049624 |
| 120 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.44491940 |
| 121 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.43222991 |
| 122 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.42833820 |
| 123 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.42271893 |
| 124 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.41962163 |
| 125 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.39621451 |
| 126 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.38231635 |
| 127 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.37753039 |
| 128 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.36116317 |
| 129 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.35414825 |
| 130 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.31115080 |
| 131 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.27095606 |
| 132 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.26458599 |
| 133 | Alzheimers disease_Homo sapiens_hsa05010 | 0.26251953 |
| 134 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.25803377 |
| 135 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.24676799 |
| 136 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.24258999 |
| 137 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.24174211 |

